SYMPOSIUM 49

 
13.15-14.45      ROOM N11       

Growth in pediatric kidney disease 
  
Chairs: Lesley Rees, London, UK
            Jane Tizard, Bristol, UK

Clinical and epidemiological aspects
George S. Reusz, Budapest, Hungary
Growth as the best clinical endpoint to assess CKD-MBD in children?
Justine Bacchetta, Lyon, France
Bone and growth biomarkers in 2015
Dieter Haffner, Hannover, Germany
Growth hormone therapy after two decades of practice
Lesley Rees, London, UK
  

back to the timetable